Pradaxa®

Pradaxa (dabigatran etexilate) is a blood thinner that was approved by the FDA in October 2010 to prevent blood clots in patients with atrial fibrillation.

In the fall of 2011, Pradaxa became the focus of regulators in Japan and New Zealand after several elderly Pradaxa patients reportedly died as a result of internal bleeding.

Long list of troubling side effects

Side effects of Pradaxa may include:

  • Frequent nosebleeds
  • Coughing up blood or blood clots
  • Severe bleeding
  • Vomiting blood
  • Vomit that looks like coffee grounds
  • Death

The FDA cautions that patients should not stop taking Pradaxa without talking to their doctor. Stopping the use of blood thinning medications can increase their risk of stroke.

Protect your rights. Get compensated for your injuries.

If you or a loved one developed serious complications after taking Pradaxa, you may be entitled to compensation. Complete the Quick Intake form at the top of this page or call our legal intake center at 1 (800) 438-6453 to receive your FREE case evaluation.